Mindset Pharma and Top Psychiatric Research Hospital, CAMH, Enter Innovative Collaboration to Build Molecular Profile of MSP-1014 Compared to Psilocybin
TORONTO, June 22, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
News
Plus Therapeutics and Biocept Announce Comprehensive Laboratory Services Agreement for the ReSPECT-LM Trial
Biocept’s CNSide™ assay provides a highly sensitive method to assess and quantify tumor cell burden…
BridgeBio Pharma Announces Early Positive Data for BBP-812, its Investigational AAV9 Gene Therapy for Canavan Disease
– These results are the first reported demonstration of rapid and robust treatment changes in…
uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, June 22, 2022 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ:…
Cyclacel Pharmaceuticals Announces That Kenneth M. Ferguson, Ph.D. Was Elected to Its Board of Directors
BERKELEY HEIGHTS, N.J., June 22, 2022 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;…
Medicenna Reports Fiscal Year 2022 Financial Results and Operational Highlights
–Cash runway extended late into calendar Q2 2023 –Tumor control achieved following MDNA11 treatment in…
ProMIS Neurosciences Announces Authorization of Series 1 Preferred Shares
TORONTO, Ontario and CAMBRIDGE, Massachusetts, June 22, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (TSX:…
ProMIS Neurosciences Announces Filing of Form 10 Registration Statement and Nasdaq Listing Application
TORONTO, Ontario and CAMBRIDGE, Massachusetts , June 22, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc….
Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B-VEC for the Treatment of Patients with Dystrophic Epidermolysis Bullosa
PITTSBURGH, June 22, 2022 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the…
Tonix Pharmaceuticals Announces Pricing of $30 Million Private Placement of Convertible Redeemable Preferred Stock
CHATHAM, N.J., June 22, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a…
TScan Therapeutics to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium
WALTHAM, Mass., June 22, 2022 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
BioCryst Announces ORLADEYO® (berotralstat) Data to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2022
RESEARCH TRIANGLE PARK, N.C., June 22, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
ACT-AD ERP P300 Latency post hoc analysis: mITT population, Wilcoxon analysis ACT-AD ERP P300 Latency…
Alladapt Announces Completion of Oversubscribed $119 Million Institutional Financing
Financing from new and existing investors will support continued development of a novel treatment for…
ProMIS Neurosciences Announces Debt Amendment and Conversion
TORONTO, Ontario and CAMBRIDGE, Massachusetts, June 22, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (TSX:…
Tilray Medical Welcomes Government of Luxembourg Delegation Visit to European Campus in Portugal
Government of Luxembourg Visits Tilray Medical Cannabis Facility in Portugual Tilray Medical Hosts Luxembourg Delegation…
Apellis Expands R&D Collaboration with Affilogic to Develop Targeted Complement Therapies for Delivery into the Brain
WALTHAM, Mass. and NANTES, France, June 22, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS)…
Ikena Oncology Receives FDA Fast Track Designation for Novel TEAD Inhibitor IK-930 to Treat Unresectable NF2-Deficient Mesothelioma
BOSTON, June 22, 2022 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted…
Sopheon Market Momentum Accelerates in First Half of 2022
Highlights include a fast-growing list of SaaS-based customers, another strategic acquisition, a key strategic partnership,…
Zscaler and AWS Expand Relationship Enabling Customers to Accelerate Onramp to the Cloud with Zero Trust Security
Zscaler’s New Posture Control CNAPP Offering Built on AWS Enables Security and DevOps Teams to…